Aclarion, Inc. (NASDAQ:ACON – Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 31st, there was short interest totalling 13,500 shares, a drop of 99.8% from the January 15th total of 7,750,000 shares. Based on an average daily trading volume, of 335,300 shares, the days-to-cover ratio is currently 0.0 days.
Aclarion Stock Up 11.7 %
ACON opened at $4.68 on Thursday. The stock has a 50-day moving average price of $25.36 and a 200-day moving average price of $52.92. Aclarion has a 1 year low of $3.86 and a 1 year high of $661.63.
Wall Street Analysts Forecast Growth
Several equities analysts have commented on the company. Ascendiant Capital Markets lowered their price objective on Aclarion from $502.50 to $435.50 and set a “buy” rating for the company in a research report on Wednesday, November 27th. Maxim Group reaffirmed a “hold” rating on shares of Aclarion in a research report on Friday, December 13th.
Aclarion Company Profile
Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.
Read More
- Five stocks we like better than Aclarion
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Profitably Trade Stocks at 52-Week Highs
- Inflation Persists, But So Do Stock Opportunities: Rally On
- 3 Dividend Kings To Consider
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Aclarion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aclarion and related companies with MarketBeat.com's FREE daily email newsletter.
